The Healthy Volunteer Autoimmunity Study

The study drug is a new potential treatment designed to combat diseases where the immune system attacks the body, such as rheumatoid arthritis. This study aims to understand how the drug is processed in the body. Participants will receive up to 4 subcutaneous (SC) injections in the abdomen during their inpatient stay.

This Phase 1 trial will provide essential information on the safety and appropriate dosage of the study drug, paving the way for further clinical development and potential future use with the goal being to treat and reduce inflammation and related symptoms in certain immune diseases.

The trial has been approved by an independent ethics committee, and eligible participants will be reimbursed for their time.

Join Us in This Journey! Your participation could be key to advancing medical research and bringing new hope to patients worldwide.

Call us at 1800 243 733 to discuss your eligibility today!